Leadership Team

The Leadership Team at Sigilon Therapeutics is responsible for setting the strategic direction of the company and overseeing the development of innovative therapies aimed at restoring normal physiology through engineered human cells. Comprising industry veterans and founders, the team collaborates to drive research efforts, ensure regulatory compliance, and navigate the complexities of bringing cutting-edge treatments from concept to clinical application, ultimately striving to improve patient outcomes in chronic disease management.